Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
AirSculpt Technologies
AIRS
$344M
| $726K | ﹤0.01% |
52,999
+38,793
| +273% | +$535K |
|
2977
Evolv Technologies
EVLV
$1.02B
| $726K | ﹤0.01% |
273,899
+6,766
| +3% | +$22.1K |
|
|
SMMF
2978
DELISTED
Summit Financial Group, Inc.
SMMF
| $724K | ﹤0.01% |
28,254
+12
| +0% | +$322 |
|
2979
Quince Therapeutics
QNCX
$24.4M
| $723K | ﹤0.01% |
583
-47
| -7% | -$64K |
|
2980
Commercial Vehicle Group
CVGI
$156M
| $721K | ﹤0.01% |
85,211
| – | – |
|
2981
Oramed Pharmaceuticals
ORMP
$180M
| $720K | ﹤0.01% |
83,219
+17,512
| +27% | +$179K |
|
|
NESR
2982
National Energy Services Reunited Corp
NESR
$2.8B
| $718K | ﹤0.01% |
85,428
+2,830
| +3% | +$26.9K |
|
2983
Arbutus Biopharma
ABUS
$861M
| $715K | ﹤0.01% |
239,713
+30,338
| +14% | +$92.9K |
|
2984
Roblox
RBLX
$26.2B
| $712K | ﹤0.01% |
15,391
+87
| +0.6% | +$5.25K |
|
2985
Atomera
ATOM
$205M
| $708K | ﹤0.01% |
54,190
+1,676
| +3% | +$25.1K |
|
2986
Standard BioTools
LAB
$339M
| $708K | ﹤0.01% |
197,153
+5,688
| +3% | +$19.6K |
|
|
ESPR
2987
DELISTED
Esperion Therapeutics
ESPR
| $707K | ﹤0.01% |
152,209
+71,549
| +89% | +$307K |
|
2988
Mastech Digital
MHH
$95.4M
| $707K | ﹤0.01% |
38,217
| – | – |
|
2989
Passage Bio
PASG
$14.4M
| $706K | ﹤0.01% |
11,381
-1,475
| -11% | -$122K |
|
|
FREE
2990
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $700K | ﹤0.01% |
97,764
+2,595
| +3% | +$23.2K |
|
|
EVLO
2991
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $695K | ﹤0.01% |
10,250
+167
| +2% | +$13.9K |
|
|
OMIC
2992
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $693K | ﹤0.01% |
3,660
+2,614
| +250% | +$605K |
|
2993
Brookfield Renewable
BEPC
$6.34B
| $691K | ﹤0.01% |
15,756
+1,700
| +12% | +$62.8K |
|
2994
Amalgamated Financial
AMAL
$1.48B
| $690K | ﹤0.01% |
38,346
+980
| +3% | +$16.7K |
|
|
GOGL
2995
DELISTED
Golden Ocean Group
GOGL
| $686K | ﹤0.01% |
+55,381
| New | +$601K |
|
2996
VistaGen Therapeutics
VTGN
$10.1M
| $686K | ﹤0.01% |
18,440
+2,259
| +14% | +$98.5K |
|
2997
Atlanticus Holdings
ATLC
$1.63B
| $685K | ﹤0.01% |
13,224
+462
| +4% | +$27.8K |
|
2998
NVE Corp
NVEC
$595M
| $685K | ﹤0.01% |
12,558
+723
| +6% | +$42.7K |
|
2999
Northrim BanCorp
NRIM
$606M
| $684K | ﹤0.01% |
62,728
+920
| +1% | +$10.2K |
|
|
CAMP
3000
DELISTED
CalAmp Corp.
CAMP
| $684K | ﹤0.01% |
4,065
+111
| +3% | +$16.9K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.